NextCure Stock (NASDAQ:NXTC), Quotes and News Summary

Q: What sector and industry does NextCure (NXTC) operate in?

NextCure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NextCure Stock (NASDAQ: NXTC) stock price, news, charts, stock research, profile.

Open	$1.300
Close	$1.350
Volume / Avg.	56.503K / 279.489K
Day Range	1.290 - 1.450
52 Wk Range	0.980 - 2.570
Market Cap	$42.134M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	36
Short Interest	3.63%
Days to Cover	1.32

Recent News

Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales guidance below estimates.

Avi Kapoor

US Stocks Higher; Initial Jobless Claims Fall To 202,000

U.S. stocks traded higher this morning, following the release of economic reports on Thursday. Following the market opening Thursday, the Dow traded up 0.24% to 37,180.82 while the NASDAQ rose 0.60% to 14,822.95. The S&P 500 also rose, gaining, 0.50% to 4,730.68.

Avi Kapoor

NextCure, LegoChem Biosciences Ink Collaborative Pact For Antibody Drug Conjugates

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Nextcure Inc

Sector

Health Care

Industry

Biotechnology

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing n...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NextCure (NXTC) stock?

You can purchase shares of NextCure (NASDAQ: NXTC) through any online brokerage.

View our list of the best stock brokerages.

Who are NextCure's (NXTC) competitors?

Other companies in NextCure’s space includes: Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX) and Immuneering (NASDAQ:IMRX).

What is the target price for NextCure (NXTC) stock?

The latest price target for NextCure (NASDAQ: NXTC) was reported by HC Wainwright & Co. on Friday, March 22, 2024. The analyst firm set a price target for 8.00 expecting NXTC to rise to within 12 months (a possible 429.80% upside). 6 analyst firms have reported ratings in the last year.

Current Stock Price for NextCure (NXTC)?

The stock price for NextCure (NASDAQ: NXTC) is $1.51 last updated April 24, 2024 at 4:24 PM EDT.

Does NextCure (NXTC) pay a dividend?

There are no upcoming dividends for NextCure.

When is NextCure (NASDAQ:NXTC) reporting earnings?

NextCure’s Q1 earnings are confirmed for Friday, May 10, 2024.

Is NextCure (NXTC) going to split?

There is no upcoming split for NextCure.

What sector and industry does NextCure (NXTC) operate in?

NextCure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-